FDA-cleared profile
Siemens Healthcare GmbH
Syngo Carbon Enterprise Access is indicated for display and rendering of medical data within healthcare institutions. The FDA summary describes an enterprise web application for DICOM, non-DICOM, multimedia, and clinical documents and standardized generic interfaces that do not control or alter connected medical devices.
Clinical fit
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Implementation
Use these fields to structure a vendor demo, security review, and implementation estimate.
The exact FDA material describes this input or interface boundary; local interoperability acceptance remains necessary.
The exact FDA material describes this release-level deployment boundary; hosting, contracts, security, availability, and site configuration remain separate evidence.
Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.
Map installed model, build, options, population, anatomy, inputs, outputs, and enabled functions to K240294 before acceptance. Later family features are not evidence for this exact submission.
exact submission · checked 2026-09-04The FDA summary describes standardized generic interfaces and enterprise display of DICOM and related data; validate identity, source metadata, routing, result association, audit, archive, and downtime behavior locally. Test representative identifiers, geometry, measurements, units, routing, failure handling, and round trips locally.
exact submission · checked 2026-09-04The FDA summary describes software-only installation on recommended common IT hardware and an enterprise-wide web application; hosting, security architecture, availability, and site responsibility remain unverified. Security, availability, retention, and service responsibilities remain unverified.
exact submission · checked 2026-09-04Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. The FDA indication is limited to display and rendering. Exact supported formats, routing, identity, retention, hosting, security, availability, and clinical workflow must be verified for the installed release and site.
exact submission · checked 2026-09-04Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs. No exact-product price was found.
product family · checked 2026-09-04Monitor by exact hardware, software, model, algorithm, reconstruction, or configuration version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: The FDA indication is limited to display and rendering. Exact supported formats, routing, identity, retention, hosting, security, availability, and clinical workflow must be verified for the installed release and site.
exact submission · checked 2026-09-04Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.
Sensitivity is not a product-wide endpoint for this system or software function. Compare only an exact endpoint, threshold, population, version, and source if later verified.
Specificity is not a product-wide endpoint for this system or software function. Compare only an exact endpoint, threshold, population, version, and source if later verified.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
FDA 510(k) substantial-equivalence review of the exact submission, device description, indications, and verification or validation documentation. · Medical data and clinical images within healthcare institutions
exact submission · Tested version: Syngo Carbon Enterprise Access (VA40A) · Sponsor or vendor studyK240294
The FDA decision material is manufacturer-submitted regulatory evidence. It is not independent clinical validation, and local technical, clinical, privacy, security, and workflow acceptance remains necessary.
Economics and lifecycle
These are common procurement questions; unknown values remain visible until a source supports them.
No public list price for the exact cleared or approved configuration was found. Obtain a written quote separating hardware or license basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.
No separate named-product payment identified in reviewed public material
Centers for Medicare & Medicaid Services · United StatesBuild a local total-cost and value model; do not infer reimbursement from FDA clearance or approval.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Exact-identifier review does not prove absence of all product-family safety signals.
Buyer worksheet
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
Recovered from the prior exact-submission extraction and normalized under the current provenance rules. Exact-name and exact-submission searches in the checked indexes returned no PubMed records and no ClinicalTrials.gov records for K240294; no published exact-submission recall was promoted. Candidate literature, registry, and non-native recall records remain quarantined unless exact product, version, and submission linkage is established. The FDA decision material remains the identity and intended-use anchor for Syngo Carbon Enterprise Access (VA40A). Pricing, complete security architecture, contracted deployment, exact reimbursement, and local interoperability remain unverified. Automated exact-name discovery found 0 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads remain unpublished until a human confirms the exact product and tested version.
Source classes: fda ai list, fda decision summary, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall
Sources
Sources accessed through 2026-09-04.
Alternatives
Siemens Medical Solutions USA, Inc.
Medical-image viewing and post-processing for diagnosis, interventional treatment planning and treatment control.
Relu BV
Relu Cloud manages, transfers, analyzes, displays, enhances, and stores oral and maxillofacial images and provides design input for dental solutions.
Beijing Infervision Healthcare Medical Technology Co., Ltd.
InferOperate Suite supports trained healthcare professionals in reading, interpreting, reporting, and treatment planning from medical images, with the submission's...
Arterys, Inc.
FDA product code QIH identifies this device class as Automated Radiological Image Processing Software. To provide automated radiological image processing and analysis tools....